Piramal Pharma Limited

Symbol: PPLPHARMA.BO

BSE

157.8

INR

Market price today

  • 1099.2857

    P/E Ratio

  • 26.5317

    PEG Ratio

  • 209.20B

    MRK Cap

  • 0.00%

    DIV Yield

Piramal Pharma Limited (PPLPHARMA-BO) Stock Split, History Data

Working capital analysis

In terms of working capital, Piramal Pharma Limited maintains a healthy position. The total current assets of the company are valued at $54644700000. This represents a growth rate of 13.008% compared to the previous year. Breaking down the current assets, the cash and investments are worth $4825600000, exhibiting a growth rate of 146.720% year-on-year. The receivables, another significant portion of the current assets, are valued at $21344300000. The year-on-year growth rate for receivables is 17.219%. The inventory, which forms a critical part of the assets, is valued at $21758800000. This represents a healthy year-on-year growth of 29.411% On the liabilities side, the company's current liabilities total $43693000000. This reflects a growth rate of 13.694% over the previous year, indicating the company's financial obligations are well under control.

2024202320222021
Cash and investments
4825.60
1955.90
2281.00
1467.30
Receavebles
21344.30
18208.90
18228.00
0.00
Inventory
21758.80
16813.70
13888.00
4208.80
Other
5269.10
5276.80
4629.00
0.00
Total Current Assets
54644.70
48354.80
40672.20
17675.00
Acc Payable
15383.70
11927.10
10263.50
5841.20
Short Term Debt
21084.20
21516.20
14195.80
1668.90
Other Current Liab
6822.10
2975.90
4022.20
64.40
Current Liabilities
43693.00
38430.50
30333.40
14716.70

Capital Structure

When examining the capital structure of Piramal Pharma Limited, it is clear that the company manages a robust portfolio. The value of their total assets clocks in at $153118100000. When juxtaposed with the previous year, this marks a growth rate of 5.435%, showcasing the company's ability to steadily grow its asset base. Turning to liabilities, the company has total liabilities amounting to $74004400000. Compared to the prior year, this reflects a growth rate of -4.499%. The long-term debt forms a sizable part of these liabilities, coming in at $24837500000. Over the last year, the long-term debt has grown by -28.740%. On the asset side, the cash and equivalent reserves are worth $4825600000. The year-on-year growth of these reserves is 146.720%. The company's common stock, another important asset, holds a value of $13229500000, growing at a rate of 10.863% from the previous year. These earnings represent the profits that Piramal Pharma Limited has chosen to reinvest in the business rather than distribute as dividends.

Total Assets

$153,118.10

Total liabilities

$74,004,400,000.00

Long term debt

$24,837.50

Cash and eqv

$4,825,600,000.00

Goodwill

$11,225.50

Retained earnings

$0.00

Common stock

$11,859.10

Enterprise Value

$11.61

Historical dividend key summary

Piramal Pharma Limited's dividend per share is $0.11, showing the earnings shared with shareholders per share. It has grown by -100.000% this year, suggesting that the company is generating increased income for shareholders and expecting future earnings growth.

YearsQ1Q2Q3Q4Total
20240.0000.0000.1100.0000.110

Net earnings per share (EPS)

Piramal Pharma Limited has an EPS of $0.77, which signifies the profit allocated per share of common stock. With a growth rate of 371.509% this year, it indicates the company's increasing profitability and potential for share value growth. This trend signals robust financial performance and future potential.

YearsQ1Q2Q3Q4Total
2024---0.770.77
2023-0.810.040.07640.41-0.28
2022-0.9-0.31-0.741.41-0.54
2021-0.31.34-1.64

Frequently Asked Question

What is the latest historical split date of the company?

The latest historical split date is N/A.

What is firm free cah flow per share (FCF per share)?

The free cah flow per share (FCF per share) is -0.262.

What is company revenue per share?

The company revenue per share is 0.056.

What are firm earnings per share?

The firm earnings per share is 0.107.

What is Piramal Pharma Limited (PPLPHARMA.BO) ROIC (return on capital)?

Piramal Pharma Limited (PPLPHARMA.BO) ROIC (return on capital) is 0.042.

What is dividend per share figure?

The dividend per share is 0.000

What is enterprise plowback ratio?

Piramal Pharma Limited (PPLPHARMA.BO) plowback ratio is N/A

What is firm enterprise value (EV)?

The enterprise value (EV) is 11.614

What is company debt to equity ratio?

The debt to equity ratio is 0.580

What are debt ratio numbers?

The debt ratio is 0.300

What is company price to sales ratio?

The price to sales ratio is 2.497